Document Detail


Sustained release nitric oxide from long-lived circulating nanoparticles.
MedLine Citation:
PMID:  20460149     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The current limitations of nitric oxide (NO) delivery systems have stimulated an extraordinary interest in the development of compounds that generate NO in a controlled and sustained manner with a heavy emphasis on the treatment of cardiovascular disease states. This work describes the positive physiological response to the infusion of NO-releasing nanoparticles prepared using a new platform based on hydrogel/glass hybrid nanoparticles. When exposed to moisture, these nanoparticles slowly release therapeutic levels of NO, previously generated through thermal reduction of nitrite to NO trapped within the dry particles. The controlled and sustained release of NO observed from these nanoparticles (NO-np) is regulated by its hydration over extended periods of time. In a dose-dependent manner, circulating NO-np both decreased mean arterial blood pressure and increased exhaled concentrations of NO over a period of several hours. Circulating NO-np induced vasodilatation and increased microvascular perfusion during their several hour circulation lifetime. Control nanoparticles (control-np; without nitrite) did not induce changes in arterial pressure, although a decrease in the number of capillaries perfused and an increase in leukocyte rolling and immobilization in the microcirculation were observed. The NO released by the NO-np prevents the inflammatory response observed after infusion of control-np. These data suggest that NO release from NO-np is advantageous relative to other NO-releasing compounds, because it does not depend on chemical decomposition or enzymatic catalysis; it is only determined by the rate of hydration. Based on the observed physiological properties, NO-np has clear potential as a therapeutic agent and as a research tool to increase our understanding of NO signaling mechanisms within the vasculature.
Authors:
Pedro Cabrales; George Han; Camille Roche; Parimala Nacharaju; Adam J Friedman; Joel M Friedman
Related Documents :
17965289 - Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure.
11454969 - Adrenomedullin increases fluid extravasation from the splenic circulation of the rat.
15569409 - Rilmenidine prevents blood pressure increase in rats with compromised nitric oxide prod...
9134909 - Nitric oxide-endothelin-1 interaction in humans.
11253169 - Mechanisms involved in the cardiovascular alterations immediately after spinal cord inj...
7599929 - Cardiovascular actions of the furoxan cas 1609, a novel nitric oxide donor.
9796239 - Block distribution and cardiovascular effects of unilateral spinal anaesthesia by 0.5% ...
380939 - Mechanical work on the lungs and work of breathing with positive end-expiratory pressur...
1418139 - Reduction in the middle cerebral artery pulsatility index after decompression of polyhy...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-05-09
Journal Detail:
Title:  Free radical biology & medicine     Volume:  49     ISSN:  1873-4596     ISO Abbreviation:  Free Radic. Biol. Med.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-13     Completed Date:  2011-01-21     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  8709159     Medline TA:  Free Radic Biol Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  530-8     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA. pcabrales@ucsd.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cricetinae
Delayed-Action Preparations
Drug Delivery Systems*
Hydrogel / chemistry
Hydrogen-Ion Concentration
Male
Nanoparticles / chemistry*
Nanotechnology / instrumentation,  methods
Nitric Oxide / administration & dosage*,  chemistry*,  metabolism,  pharmacokinetics
Particle Size
Signal Transduction
Grant Support
ID/Acronym/Agency:
P01 HL071064/HL/NHLBI NIH HHS; P01 HL071064-05/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Delayed-Action Preparations; 10102-43-9/Nitric Oxide; 25852-47-5/Hydrogel
Comments/Corrections
Comment In:
Free Radic Biol Med. 2010 Aug 15;49(4):528-9   [PMID:  20639121 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vitro Neurotoxicity of Magnetic Resonance Imaging (MRI) Contrast Agents: Influence of the molecul...
Next Document:  Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannab...